Unusual visualization of an adrenal carcinoma on NP-59 scintiscan

Journal of the Formosan Medical Association

Volumn 105, Issue 4, 2006, Pages 340-345

  Wang, Fan Fen ^c   Chang, Yen Hwa ^a   Pan, Chin Chen ^a   Tu, Dom Gene ^b   Won, Justin Ging Shing ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Section of Infectious Diseases   (Taiwan)

Author keywords

Adrenocortical carcinoma; NP 59 scan; Virilization

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; ALDOSTERONE; ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; LUTEINIZING HORMONE; MITOTANE; PRASTERONE SULFATE; PROLACTIN; STEROID; TESTOSTERONE;

ADOLESCENT; ADRENAL CORTEX CARCINOMA; ADRENAL SCINTISCANNING; ARTICLE; CASE REPORT; FEMALE; HISTOPATHOLOGY; HORMONE DETERMINATION; HORMONE SYNTHESIS; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; MENARCHE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRIMARY AMENORRHEA; TUMOR VOLUME; VIRILIZATION;

EID: 33645277366     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60126-1     Document Type: Article

References (24)

1. Mansmann G, Lau J, Balk E, et al. The clinical inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004;25:309-40.
2. Schteingart DE, Homan D. Management of adrenal cancer. In: Margioris AN, Chrousos GP, eds. Adrenal Disorder, 2nd edition. Totowan, NJ: Humana Press, 2002:193-202.
3. Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990;332:1195-201.
4. Gross MD, Shapiro B, Thrall JH, et al. The scintigraphic imaging of endocrine organs. Endocr Rev 1984;5:221-81.
5. Barzon L, Scaroni C, Sonino N, et al. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 1998;83:55-62.
6. Schteingart DE, Seabold JE, Gross MD, et al. Iodocholesterol adrenal tissue uptake and imaging in adrenal neoplasms. J Clin Endocrinol Metab 1981;52:1156-61.
7. Weiss LM, Mederios LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989;13:202-6.
8. 131I-19-iodocholesterol by an adrenal cortical carcinoma and its metastases. J Clin Endocrinol Metab 1976;43:248-51.
9. Drane WE, Graham MM, Nelp WB. Imaging of an adrenal cortical carcinoma and its skeletal metastasis. J Nucl Med 1983;24:710-2.
10. Pasieka JL, McLeod MK, Thompson NW, et al. Adrenal scintigraphy of well-differentiated (functioning) adrenocortical carcinomas: potential surgical pitfalls. Surgery 1992; 112:884-90.
11. Greathouse DJ, McDermott MT, Kidd GS, et al. Pure primary hyperaldosteronism due to adrenal cortical carcinoma. Am J Med 1984;76:1132-6.
12. Sakashita S, Kashiwagi A, Maru A, et al. Primary aldosteronism due to adrenal cortical carcinoma. J Urol 1984;132: 959-61.
13. Shenker Y, Gross MD, Grekin RJ, et al. The scintigraphic localization of mineralcorticoid-producing adrenocortical carcinoma. J Endocrinol Invest 1986;9:115-20.
14. Scott HW, Sussman CR, Page DL, et al. Primary hyperaldosteronism caused by adrenocortical carcinoma. World J Surg 1986;10:646-53.
15. 131I-19-iodocholesterol visualization of an adrenal carcinoma without clinical manifestations. J Nucl Biol Med 1975;19:225-7.
16. Ng L, Libertino JM. Adrenacortical carcinoma: diagnosis, evaluation and treatment. J Urol 2003;169:5-11.
17. Saez JM, Loras B, Mrera AM, et al. Studies of androgens and their precursors in adrenocortical virilizing carcinoma. J Clin Endocr 1971;32:462-9.
18. Shiroto MD, Ando H, Ebitani I. Normotensive primary aldosteronism. Am J Med 1979;69:603-6.
19. Sasano H, Suzuki T, Nagura H, et al. Steroidogenesis in human adrenocortical carcinoma: biochemical activities, immunohistochemistry, and in situ hybridization of steroidogenic enzymes and histopathologic study in nine cases. Hum Pathol 1993;24:397-404.
20. Bulun SE, Adashi EY. The physiology and pathology of the female reproductive axis. In: Larsen PR, Kronenberg HM, Melmed S, et al, eds. Williams Textbook of Endocrinology, 10th edition. Philadelphia: WB Saunders, 2003:587-664.
21. Latronico AC, Chrousos GP. Adrenalcortical tumors. J Clin Endocrinol Metab 1997;82:1317-24.
22. Villee DB, Rotner H, Kliman B, et al. Androgen synthesis in a patient with virilizing adrenocortical carcinoma. J Clin Endocr 1967;27:1112-22.
23. Spaulding SW, Takaai M, Isawa Y. Increased 17-B hydroxy-steroid dehydrogenase activity in a masculinizing adrenal adenoma in a patient with isolated testosterone overproduction. J Clin Endocrinol Metab 1980;50:537-44.
24. Huvos AG, Hajdu SI, Brasfield RD, et al. Adrenal cortical carcinoma. Clinicopathologic study of 34 cases. Cancer 1970;25:354-61.